Kreston Reeves supports biopharmaceutical deal with transaction advisory services

June 14, 2024

Kreston Reeves has successfully provided transaction advisory services to A4P Consulting on its sale to LabConnect, a US-based leader in global central laboratory services and scientific-focused Functional Service Provider (FSP) solutions.

Dual-location: A4P Consulting

Headquartered in Discovery Park, Sandwich, Kent, with a subsidiary in Appenzell, Switzerland, A4P Consulting specialises in regulated bioanalysis and genomics, biomarker strategy, personalised healthcare, biosample operations, and bespoke logistics solutions. A4P serves a diverse clientele across various therapeutic areas, partnering with pharmaceutical and biotechnology companies, contract research organisations, and foundations/non-governmental organisations.

LabConnect’s expanding capabilities

LabConnect, renowned for its innovative Central Laboratory Services and scientific FSP solutions, supports clinical trials of all sizes and complexity globally. As the demands of clinical trials and drug development have increased, LabConnect meets these challenges by providing comprehensive scientific and technical expertise, strategic lab data collection advice, and end-to-end analytical and logistical solutions tailored to each trial.

Benefits of the acquisition

The acquisition of A4P Consulting by LabConnect significantly enhances LabConnect’s industry-leading position. This strategic move unlocks exciting opportunities for both companies to broaden their geographic reach and enhance their service offerings. Ian James, PhD., Co-Founder and CEO of A4P, expressed his enthusiasm for the future:

“I am excited for the future for both our customers and our valued staff, and grateful to the team at Kreston Reeves for bringing their experience and insights to get this deal across the line.”

Kreston Reeves’ key transaction advisers

The Kreston Reeves transaction advisory services team, led by Partner Scott Mile and Business Advisory Manager Jak Hill, with tax advice from Director Michael Haig, played a pivotal role in bringing this deal to fruition. Their expertise and insights were instrumental in navigating the complexities of the transaction, ensuring a successful outcome for all parties involved. This highlights Kreston Reeves’ exceptional capabilities in transaction advisory services.

Future prospects for LabConnect and A4P Consulting

Dawn Sherman, CEO of LabConnect, highlighted the complementary experience and expertise that A4P brings. The combined strengths of both companies provide clients with unprecedented access to cutting-edge scientific solutions, furthering the mission to create healthier communities and improve patient lives by accelerating the development of medicines.

If you would like to speak to one of our experts about transaction advisory services at Kreston Global, please get in touch.